UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of antidepressant agents and the risk of type 2 diabetes

European journal of clinical pharmacology, 2012-09, Vol.68 (9), p.1295-1302

2012

Volltextzugriff (PDF)

PRO21 HEALTH CARE COST AND UTILIZATION AMONG CHILDREN WITH IMMUNE THROMBOCYTOPENIA ENROLLED IN TEXAS MEDICAID

Value in health, 2020-05, Vol.23, p.S332-S332

2020

Volltextzugriff (PDF)

PND57 COMPARISON OF CLAIMS-BASED MULTIPLE SCLEROSIS DISEASE SEVERITY MEASURES IN THE MEDICARE POPULATION

Value in health, 2020-05, Vol.23, p.S269-S270

2020

Volltextzugriff (PDF)

PND86 REPLICATION OF A US CLAIMS BASED ALGORITHM TO IDENTIFY MULTIPLE SCLEROSIS DISEASE SEVERITY BASED ON HEALTHCARE COSTS

Value in health, 2019-05, Vol.22, p.S286-S286

2019

Volltextzugriff (PDF)

PRO39 PREVALENCE OF PRIMARY IMMUNE THROMBOCYTOPENIA AMONG TEXAS MEDICAID BENEFICIARIES: ANALYSES OF AN ADMINISTRATIVE CLAIMS DATABASE

Value in health, 2019-05, Vol.22, p.S342-S342

2019

Volltextzugriff (PDF)

PDG81 EVALUATION OF PROGESTERONE (17-ALPHA HYDROXYPROGESTERONE CAPROATE) UTILIZATION AND ADHERENCE IN WOMEN WITH A HIGH-RISK PREGNANCY

Value in health, 2019-05, Vol.22, p.S176-S176

2019

Volltextzugriff (PDF)

Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database

Diabetes, obesity & metabolism, 2013-10, Vol.15 (10), p.901-905

2013

Volltextzugriff (PDF)

Costs for Diabetic Patients Receiving Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in US Medicare and Commercial Insurance Plans

Value in health, 2015-11, Vol.18 (7), p.A601-A602

2015

Volltextzugriff (PDF)

Pharmacoeconomics Education In Who Eastern Mediterranean Region

Value in health, 2015-05, Vol.18 (3), p.A34-A34

2015

Volltextzugriff (PDF)

Estimates of emergency department (ED) and inpatient care costs for opioid-abuse related events: 2006-2008

The journal of pain, 2012-04, Vol.13 (4), p.S38-S38

2012

Volltextzugriff (PDF)

CO28 Impact of Value-Based Insurance Design on Medication Adherence in Patients with Asthma and/or COPD in an Employee Health Plan: An Interrupted Time Series Analysis

Value in health, 2022-07, Vol.25 (7), p.S309

2022

Volltextzugriff (PDF)

HPR47 Impact of Zero-Dollar Copayment and Premium Changes on Medication Adherence in Diabetic Patients in an Employee Health Group

Value in health, 2022-07, Vol.25 (7), p.S474-S475

2022

Volltextzugriff (PDF)

PHP72 ASSESSING THE QUALITY OF PHARMACOECONOMIC STUDIES IN INDIA: A SYSTEMATIC REVIEW

Value in health, 2011, Vol.14 (3), p.A24-A24

2011

Volltextzugriff (PDF)

PCV106 ANTIHYPERTENSIVE AGENT UTILIZATION AMONG PATIENTS WITH UNCONTROLLED HYPERTENSION IN THE UNITED STATES

Value in health, 2019-11, Vol.22, p.S561-S561

2019

Volltextzugriff (PDF)

Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk

Drug safety, 2006-01, Vol.29 (7), p.621-632

2006

Volltextzugriff (PDF)

PDG19 Prescription Opioid Use in Women during Pregnancy - A Retrospective Analysis Using Texas Medicaid Prescription Claims Data

Value in health, 2021-06, Vol.24, p.S90-S90

2021

Volltextzugriff (PDF)

PDG90 OPIOID USE AMONG MIGRAINE PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT (ED) OF A LARGE TERTIARY CARE INTEGRATED DELIVERY NETWORK IN TEXAS

Value in health, 2019-05, Vol.22, p.S177-S177

2019

Volltextzugriff (PDF)

PDG44 COPRESCRIBING OF OPIOIDS AND BENZODIAZEPINES IN TEXAS MEDICAID ENROLLEES

Value in health, 2020-05, Vol.23, p.S137-S137

2020

Volltextzugriff (PDF)

PRO75 PRESCRIPTION MEDICATION UTILIZATION FOR THE MANAGEMENT OF SICKLE CELL DISEASE BY AGE GROUP

Value in health, 2020-05, Vol.23, p.S342-S342

2020

Volltextzugriff (PDF)

PDG3 EVALUATION OF PROGESTERONE (17-ALPHA HYDROXYPROGESTERONE CAPROATE (17-OHPC)) UTILIZATION, ADHERENCE, AND OUTCOMES IN WOMEN WITH A HIGH-RISK PREGNANCY

Value in health, 2020-05, Vol.23, p.S129-S129

2020

Volltextzugriff (PDF)

PND114 OPIOID USE AMONG MIGRAINE PATIENTS AT THE EMERGENCY DEPARTMENTS AND SUBSEQUENT MIGRAINE-RELATED EMERGENCY DEPARTMENT VISITS

Value in health, 2020-05, Vol.23, p.S281-S281

2020

Volltextzugriff (PDF)

PNS199 A REVIEW OF POLICIES REGARDING PATIENT-REPORTED OUTCOMES (PRO) FROM THE FOOD AND DRUG ADMINISTRATION (FDA) AND EUROPEAN MEDICINES AGENCY (EMA)

Value in health, 2020-05, Vol.23, p.S320-S320

2020

Volltextzugriff (PDF)

PDB88 MEASURING INSULIN ADHERENCE USING ADJUSTED MEDICATION POSSESSION RATIO: AN EXAMINATION OF THE METHODOLOGY

Value in health, 2020-05, Vol.23, p.S124-S124

2020

Volltextzugriff (PDF)

PCN117 COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB USED IN CHINESE PATIENTS WITH METASTATIC COLORECTAL CANCER

Value in health, 2020-05, Vol.23, p.S43-S43

2020

Volltextzugriff (PDF)

PCN299 A REVIEW OF PATIENT-REPORTED OUTCOMES LABELING FOR ONCOLOGY PRODUCTS APPROVED BY FDA AND EMA FROM 2017 TO 2018

Value in health, 2020-05, Vol.23, p.S76-S76

2020

Volltextzugriff (PDF)

1 – 25 von 198

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(178)

Publikationsform

Artikel
(198)

Sprache

Englisch
(198)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of antidepressant agents and the risk of type 2 diabetes

PRO21 HEALTH CARE COST AND UTILIZATION AMONG CHILDREN WITH IMMUNE THROMBOCYTOPENIA ENROLLED IN TEXAS MEDICAID

PND57 COMPARISON OF CLAIMS-BASED MULTIPLE SCLEROSIS DISEASE SEVERITY MEASURES IN THE MEDICARE POPULATION

PND86 REPLICATION OF A US CLAIMS BASED ALGORITHM TO IDENTIFY MULTIPLE SCLEROSIS DISEASE SEVERITY BASED ON HEALTHCARE COSTS

PRO39 PREVALENCE OF PRIMARY IMMUNE THROMBOCYTOPENIA AMONG TEXAS MEDICAID BENEFICIARIES: ANALYSES OF AN ADMINISTRATIVE CLAIMS DATABASE

PDG81 EVALUATION OF PROGESTERONE (17-ALPHA HYDROXYPROGESTERONE CAPROATE) UTILIZATION AND ADHERENCE IN WOMEN WITH A HIGH-RISK PREGNANCY

Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database

Costs for Diabetic Patients Receiving Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in US Medicare and Commercial Insurance Plans

Pharmacoeconomics Education In Who Eastern Mediterranean Region

Estimates of emergency department (ED) and inpatient care costs for opioid-abuse related events: 2006-2008

CO28 Impact of Value-Based Insurance Design on Medication Adherence in Patients with Asthma and/or COPD in an Employee Health Plan: An Interrupted Time Series Analysis

HPR47 Impact of Zero-Dollar Copayment and Premium Changes on Medication Adherence in Diabetic Patients in an Employee Health Group

PHP72 ASSESSING THE QUALITY OF PHARMACOECONOMIC STUDIES IN INDIA: A SYSTEMATIC REVIEW

PCV106 ANTIHYPERTENSIVE AGENT UTILIZATION AMONG PATIENTS WITH UNCONTROLLED HYPERTENSION IN THE UNITED STATES

Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk

PDG19 Prescription Opioid Use in Women during Pregnancy - A Retrospective Analysis Using Texas Medicaid Prescription Claims Data

PDG90 OPIOID USE AMONG MIGRAINE PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT (ED) OF A LARGE TERTIARY CARE INTEGRATED DELIVERY NETWORK IN TEXAS

PDG44 COPRESCRIBING OF OPIOIDS AND BENZODIAZEPINES IN TEXAS MEDICAID ENROLLEES

PRO75 PRESCRIPTION MEDICATION UTILIZATION FOR THE MANAGEMENT OF SICKLE CELL DISEASE BY AGE GROUP

PDG3 EVALUATION OF PROGESTERONE (17-ALPHA HYDROXYPROGESTERONE CAPROATE (17-OHPC)) UTILIZATION, ADHERENCE, AND OUTCOMES IN WOMEN WITH A HIGH-RISK PREGNANCY

PND114 OPIOID USE AMONG MIGRAINE PATIENTS AT THE EMERGENCY DEPARTMENTS AND SUBSEQUENT MIGRAINE-RELATED EMERGENCY DEPARTMENT VISITS

PNS199 A REVIEW OF POLICIES REGARDING PATIENT-REPORTED OUTCOMES (PRO) FROM THE FOOD AND DRUG ADMINISTRATION (FDA) AND EUROPEAN MEDICINES AGENCY (EMA)

PDB88 MEASURING INSULIN ADHERENCE USING ADJUSTED MEDICATION POSSESSION RATIO: AN EXAMINATION OF THE METHODOLOGY

PCN117 COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB USED IN CHINESE PATIENTS WITH METASTATIC COLORECTAL CANCER

PCN299 A REVIEW OF PATIENT-REPORTED OUTCOMES LABELING FOR ONCOLOGY PRODUCTS APPROVED BY FDA AND EMA FROM 2017 TO 2018

Suchergebnisse filtern